Form 4: Edgewise Therapeutics Director Receives Stock Option Grant

Director Christopher Nathan Martin was granted 16,377 stock options in Edgewise Therapeutics, Inc. as part of a standard equity compensation arrangement.

Summary

• Director Christopher Nathan Martin received a grant of 16,377 stock options on June 5, 2026.
• The options have an exercise price of $35.59 per share.
• The options are scheduled to vest on the earlier of June 5, 2027, or the business day prior to the 2027 annual meeting of stockholders.
• The options expire on June 5, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on the company's immediate financial position.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• The grant results in potential future dilution for existing shareholders upon exercise.

Risks

• Market volatility affecting the value of the underlying common stock relative to the $35.59 exercise price.

Future Outlook

The options vest in one year, aligning the director's tenure with the company's performance through the 2027 annual meeting cycle.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the biotechnology sector to attract and retain board expertise while ensuring long-term alignment with corporate milestones.

Comparison to Industry Standards

• The grant size and vesting schedule are consistent with typical director compensation packages for mid-cap biotechnology firms.
• The use of a one-year cliff vesting period is a standard governance practice for board-level equity awards.

Stakeholder Impact

• Minor dilution impact on existing shareholders upon future exercise of options.

Next Steps

• Vesting of options on June 5, 2027, or the day prior to the 2027 annual meeting.

Key Dates

Keywords

Edgewise Therapeutics, EWTX, Form 4, Insider Trading, Stock Options, Director Compensation